Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis and breast cancer.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Rehabilitation interventions in multiple sclerosis: an overview.
FDA warns about seizures linked to MS drug
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Epstein-Barr virus: an important vaccine target for cancer prevention.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Anejaculatory infertility due to multiple sclerosis.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
3D models of human ERα and ERβ complexed with coumestrol.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis

Pages